Roche to acquire US biotech firm Ignyta for $1.7 billion
22 December 2017
Roche weighs options for struggling diabetes-care business, including a sale
01 February 2017
Natco gets USFDA approval for generic version of Roche’s influenza drug Tamiflu
06 August 2016
Roche's blood cancer drug Gazyva trials show no significant improvements over older drug
18 July 2016
Novartis to sell stake in Roche worth $13.8 bn
25 April 2016
Roche in talks to buy gene sequencing systems maker Pacific Biosciences of California
03 February 2016
Gujarat, Telangana freeze use of Roche’s Avastin after 15 develop eye problems
20 January 2016
Roche to buy US biotech group Adheron Therapeutics in a $580 mn deal
10 October 2015
Roche to buy GeneWEAVE BioSciences
14 August 2015
Trials show Roche drug halves tumours in lung cancers
14 May 2015
Roche to acquire Foundation Medicine in a $1-bn deal
13 January 2015
23andMe Inc, Genentech to analyse genomes of 3,000 Parkinson’s patients
09 January 2015
Roche to buy Austrian biotechnology company Dutalys in $489 mn deal
20 December 2014
Roche to acquire prenatal tester for risks in down syndrome Ariosa Diagnostics
02 December 2014
Roche to buy InterMune for $8.3 bn
25 August 2014
AstraZeneca, Roche, Qiagen in collaboration on lung cancer tests
28 July 2014
Genentech to pay up to $1.7 bn for oncology firm Seragon
03 July 2014
Italian regulator fines Novartis, Roche $250 mn over collusion in eye treatment drugs
06 March 2014
May collaborate, not take over Roche: Novartis
03 March 2014
Roche to share Avastin data from trial to determine benefits to glioblastoma patients
21 February 2014
Roche to pay $458 mn for rights to experimental antibiotic
05 November 2013
Roche denies raising money to acquire BioMarin Pharmaceuticals
20 September 2013
Roche in exclusive cancer vaccine development deal with Inovio Pharmaceuticals
11 September 2013
Swiss drugmaker Roche eyes Alexion Pharmaceuticals
13 July 2013
Swiss drugmaker Roche buys US blood testing company CMI for $220 mn
02 July 2013
Roche inks $600 mn hormone disorders development deal with Chiasma
18 February 2013
Illumina reportedly agrees to Roche's $8.2-bn takeover offer
21 December 2012
Roche’s patent on Hepatitis C drug set aside
02 November 2012
Roche ends $6.7-bn hostile bid for Illumina
19 April 2012
ISS backs Illumina board; urges rejection of Roche's $6.7-bn bid
07 April 2012
Letter to Roche from Illumina’s president and CEO
03 April 2012
Illumina rejects Roche’s $6.7-bn bid
03 April 2012
Roche increases hostile offer for Illumina to $6.7 billion
29 March 2012
Roche asks Illumina investors to accept its $5.7-bn bid
21 March 2012
Roche extends hostile $5.7-billion offer for Illumina
27 February 2012
Illumina rejects Roche's $5.7- bn hostile bid
08 February 2012
Roche Diagnostics plans Jafza headquarters for Middle East
30 January 2012
Roche to buy hepatitis C drug developer Anadys for $230 million
18 October 2011
Roche to acquire cervical cancer detection firm MTM Laboratories
19 July 2011
Roche to axe 4,800 jobs in $2.1-b restructuring
17 November 2010
GSK sues Roche over Genentech's cancer drug patent infringement
23 September 2010
Roche bets $1.1 billion on Aileron Therapeutics stapled peptide
25 August 2010
Roche to buy cancer diagnostic firm BioImagene Inc for $100 million
24 August 2010
Roche buys Lonza’s Singapore unit for $360 million
02 September 2009
SC refuses to hear Roche's patent plea against Cipla
28 August 2009
Roche clinches Genentech deal for $47 billion
12 March 2009
Roche calls Genentech’s $112 a share demand unreasonable, may reach agreement on $95 a share
10 March 2009
Roche raises Genentech offer from $86.50 to $93 a share
07 March 2009
Genentech tells shareholders to reject Roche bid
24 February 2009
Sale of Genentech skin drug `Raptiva' suspended after 3 deaths
20 February 2009
Carl Icahn attempts to get nominees on Biogen board after blockbuster drug drags
07 February 2009
Roche lowers Genentech bid to $42 billion
30 January 2009
Roche confirms plans to acquire remaining 44 per cent in Genentech
21 October 2008
Genentech Says Employee Plan May Cost $371 Million
23 August 2008
Genentech rejects Roche’s $43.7-billion takeover offer as too low
13 August 2008
Roche bids for Genentech on Monday, acquires Mirus on Tuesday and Arius on Wednesday
25 July 2008
Roche makes a $43.7-billion bid for Genentech
21 July 2008
Delhi HC upholds ruling in Cipla-Roche cancer drug row
23 April 2008
Cipla to continue selling its version of Roche's lung cancer treatment drug
20 March 2008
Roche to acquire Ventana for $89.50 per share
23 January 2008
Roche takes Teva to court over generic osteoporosis drug
11 September 2007
Roche secures US court injunction for its Ventana bid
23 August 2007
Rebuffed by Ventana, Roche may increase its $3-billion bid
13 July 2007
Roche goes to court over Ventana''s poison-pill defence
05 July 2007
Roche makes hostile offer for Ventana
27 June 2007
Roche buys Toyama''s arthritis drug for $370 million
26 June 2007
Roche reports strong global sales for Tamiflu
27 April 2006
Roche grants Tamiflu licence to Hyderabad firm Hetero Drugs
24 December 2005
On the clinical trial trail
11 March 2005
Novartis acquires 20 per cent stake in Roche
08 May 2001
 search domain-b